Relationship between Hypercholesterolemia, Lipid-Lowering Therapy and Coronary Flow Velocity Reserve Evaluated by Stress Transesophageal Echocardiography in Patients with a Negative Coronary Angiogram

Echocardiography

Volumn 21, Issue 1, 2004, Pages 37-41

  Nemes, Attila ^a   Neu, Klára ^a   Forster, Tamás ^a   Gruber, Noémi ^a   Csanády, Miklós ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Cholesterol level; Coronary flow; Ischemic heart disease; Transesophageal echocardiography

Indexed keywords

ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CHOLESTEROL; CIPROFIBRATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; DIURETIC AGENT; FENOFIBRATE; FIBRIC ACID DERIVATIVE; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC ACID DERIVATIVE; SIMVASTATIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; EVALUATION; FEMALE; FLOW RATE; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STRESS TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

ADULT; AGED; ANTICHOLESTEREMIC AGENTS; BLOOD FLOW VELOCITY; CHOLESTEROL; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY DISEASE; DIPYRIDAMOLE; ECHOCARDIOGRAPHY, STRESS; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FATTY ACIDS, MONOUNSATURATED; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; INDOLES; MALE; MIDDLE AGED; VASODILATOR AGENTS;

EID: 0842291612     PISSN: 07422822     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0742-2822.2004.03009.x     Document Type: Article

References (12)

1. Iliceto S, Marangelli V, Memmola C, et al: Transesophageal Doppler echocardiography evaluation of coronary blood flow velocity in baseline conditions and during dipyridamole-induced coronary vasodilation. Circulation 1991;83:61-69 .
2. Baumgart D, Haude M, Liu F, et al: Current concepts of coronary flow reserve for clinical decision making during cardiac catheterization. Am Heart J 1998;136:136-149.
3. Strauer BE: The concept of coronary flow reserve. J Cardiovasc Pharmacol 1992;19(Suppl. 5):S67-S80.
4. Yokoyama I, Ohtake T, Momomura S, et al: Reduced coronary flow reserve in hypercholesterolemic patients without overt coronary stenosis. Circulation 1996;94:3232-3238.
5. Yokoyama I, Murakami T, Ohtake T, et al: Reduced coronary flow reserve in familial hypercholesterolemia. J Nucl Med 1996;37:1937-1942.
6. Pitkanen OP, Nuutila P, Raitakari OT, et al: Coronary flow reserve in young men with familial combined hyperlipidaemia. Circulation 1999;99:1678-1684.
7. Baller D, Notohamiprodjo G, Gleichmann U, et al: Improvement in coronary flow reserve determined by positron emission tomography after 6 months of cholesterol-lowering therapy in patients with early stages of coronary atherosclerosis. Circulation 1999;99:2871-2875.
8. Pitkanen OP, Raitakari OT, Niinikoski H, et al: Coronary flow reserve is impaired in young men with familial hypercholesterolemia. J Am Coll Cardiol 1996;28:1705-1711.
9. Mellwig KP, Baller D, Gleichmann U, et al: Improvement of coronary vasodilatation capacity through single LDL apheresis. Atherosclerosis 1998;139:173-178.
10. Baller D, Gleichmann U, Notohamiprodjo G, et al: Improved coronary vasodilator capacity by drug lipid lowering therapy in patients in the early stage of coronary atherosclerosis with reduced coronary reserves and moderate LDL hypercholesterolemia. Z Kardiol 1998;87(Suppl.2):136-144.
11. Kaufmann PA, Gnecchi-Ruscone T, Schafers KP, et al: Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia. J Am Coll Cardiol 2000;36:103-109.
12. Guethlin M, Kasel AM, Coppenrath K, et al: Delayed response of myocardial reserve to lipid-lowering therapy with fluvastatin. Circulation 1999;99:475-481.